Citigroup’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-384,383
| Closed | -$16M | – | 5859 |
|
|
2023
Q2 | $16M | Sell |
384,383
-10,950
| -3% | -$450K | 0.01% | 925 |
|
|
2023
Q1 | $16.3M | Buy |
395,333
+360,952
| +1,050% | +$15.4M | 0.01% | 916 |
|
|
2022
Q4 | $1.42M | Sell |
34,381
-1,075,081
| -97% | -$43.5M | ﹤0.01% | 2305 |
|
|
2022
Q3 | $48.6M | Buy |
1,109,462
+5,403
| +0.5% | +$262K | 0.03% | 388 |
|
|
2022
Q2 | $54.3M | Buy |
1,104,059
+975,455
| +758% | +$52.3M | 0.04% | 362 |
|
|
2022
Q1 | $7.29M | Buy |
128,604
+107,197
| +501% | +$5.69M | ﹤0.01% | 1464 |
|
|
2021
Q4 | $1.12M | Buy |
21,407
+12,841
| +150% | +$698K | ﹤0.01% | 3124 |
|
|
2021
Q3 | $514K | Sell |
8,566
-657
| -7% | -$40.5K | ﹤0.01% | 3586 |
|
|
2021
Q2 | $625K | Sell |
9,223
-91,463
| -91% | -$6.24M | ﹤0.01% | 3548 |
|
|
2021
Q1 | $6.6M | Buy |
100,686
+78,847
| +361% | +$4.73M | ﹤0.01% | 1621 |
|
|
2020
Q4 | $1.23M | Sell |
21,839
-4,583
| -17% | -$225K | ﹤0.01% | 3335 |
|
|
2020
Q3 | $1.28M | Sell |
26,422
-10,688
| -29% | -$576K | ﹤0.01% | 3050 |
|
|
2020
Q2 | $2.06M | Sell |
37,110
-761
| -2% | -$44K | ﹤0.01% | 2778 |
|
|
2020
Q1 | $1.92M | Sell |
37,871
-1,347
| -3% | -$90.3K | ﹤0.01% | 2520 |
|
|
2019
Q4 | $3.03M | Buy |
39,218
+21,399
| +120% | +$1.51M | ﹤0.01% | 2525 |
|
|
2019
Q3 | $1.13M | Buy |
17,819
+5,389
| +43% | +$337K | ﹤0.01% | 3506 |
|
|
2019
Q2 | $728K | Buy |
12,430
+2,034
| +20% | +$120K | ﹤0.01% | 4026 |
|
|
2019
Q1 | $590K | Sell |
10,396
-20,857
| -67% | -$1.11M | ﹤0.01% | 4002 |
|
|
2018
Q4 | $1.55M | Buy |
31,253
+14,097
| +82% | +$848K | ﹤0.01% | 2931 |
|
|
2018
Q3 | $1.22M | Buy |
17,156
+5,194
| +43% | +$330K | ﹤0.01% | 3268 |
|
|
2018
Q2 | $624K | Buy |
11,962
+6,422
| +116% | +$336K | ﹤0.01% | 3859 |
|
|
2018
Q1 | $290K | Buy |
5,540
+4,327
| +357% | +$219K | ﹤0.01% | 4562 |
|
|
2017
Q4 | $71K | Sell |
1,213
-19,038
| -94% | -$1.08M | ﹤0.01% | 5925 |
|
|
2017
Q3 | $1.12M | Sell |
20,251
-14,720
| -42% | -$974K | ﹤0.01% | 3247 |
|
|
2017
Q2 | $2.69M | Buy |
34,971
+33,937
| +3,282% | +$2.54M | ﹤0.01% | 2277 |
|
|
2017
Q1 | $77K | Sell |
1,034
-31,152
| -97% | -$2.26M | ﹤0.01% | 5403 |
|
|
2016
Q4 | $2.17M | Buy |
32,186
+10,790
| +50% | +$696K | ﹤0.01% | 2840 |
|
|
2016
Q3 | $1.43M | Buy |
21,396
+4,032
| +23% | +$257K | ﹤0.01% | 2846 |
|
|
2016
Q2 | $1.04M | Sell |
17,364
-18,971
| -52% | -$1.03M | ﹤0.01% | 2919 |
|
|
2016
Q1 | $1.77M | Buy |
36,335
+29,178
| +408% | +$1.32M | ﹤0.01% | 2644 |
|
|
2015
Q4 | $388K | Buy |
7,157
+6,225
| +668% | +$317K | ﹤0.01% | 4129 |
|
|
2015
Q3 | $46K | Buy |
932
+235
| +34% | +$12.1K | ﹤0.01% | 5498 |
|
|
2015
Q2 | $33K | Sell |
697
-34
| -5% | -$1.59K | ﹤0.01% | 5800 |
|
|
2015
Q1 | $33K | Buy |
731
+686
| +1,524% | +$31.9K | ﹤0.01% | 5793 |
|
|
2014
Q4 | $2K | Sell |
45
-1,574
| -97% | -$65.6K | ﹤0.01% | 6887 |
|
|
2014
Q3 | $56K | Sell |
1,619
-2,048
| -56% | -$72.9K | ﹤0.01% | 5234 |
|
|
2014
Q2 | $130K | Buy |
3,667
+1,381
| +60% | +$47.3K | ﹤0.01% | 4481 |
|
|
2014
Q1 | $88K | Sell |
2,286
-14,592
| -86% | -$536K | ﹤0.01% | 5103 |
|
|
2013
Q4 | $546K | Buy |
16,878
+10,032
| +147% | +$301K | ﹤0.01% | 3717 |
|
|
2013
Q3 | $167K | Sell |
6,846
-25,081
| -79% | -$617K | ﹤0.01% | 4321 |
|
|
2013
Q2 | $791K | Buy |
+31,927
| New | +$699K | ﹤0.01% | 3083 |
|
Other funds holding NUVA
Citigroup's NUVA Position: Q3 2023 in Review
Citigroup sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 384,383 shares — an estimated $16M sold.
Citigroup first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $54.3M in Q2 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Citigroup reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Citigroup sold 384,383 NuVasive, Inc. shares in Q3 2023, an estimated $16M.
- Citigroup first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
- Citigroup's NuVasive, Inc. position peaked at $54.3M in Q2 2022.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.